QRG Capital Management Inc. Decreases Stock Position in Cigna Group $CI

Key Points

• QRG Capital Management cut its stake in Cigna by 66.2% in Q4, selling 28,197 shares and leaving it with 14,415 shares worth about $3.97 million.
• Cigna beat Q1 estimates with EPS of $7.79 (vs. $7.60 est.) and revenue of $68.52 billion (vs. $66.29B est.), set FY‑2026 guidance around $30.35 EPS, and has an average analyst price target of about $338.35 with mostly Buy ratings.
• The company announced a quarterly dividend of $1.56 per share (annualized $6.24) for a yield of ~2.2%, payable June 18 with an ex‑dividend date of June 4.

QRG Capital Management Inc. cut its holdings in Cigna Group (NYSE:CI - Free Report) by 66.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,415 shares of the health services provider's stock after selling 28,197 shares during the quarter. QRG Capital Management Inc.'s holdings in Cigna Group were worth $3,967,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Beacon Financial Strategies CORP purchased a new stake in shares of Cigna Group during the fourth quarter valued at $28,000. Lodestone Wealth Management LLC purchased a new position in Cigna Group in the 4th quarter worth about $32,000. Collier Financial purchased a new position in Cigna Group in the 3rd quarter worth about $34,000. Activest Wealth Management lifted its stake in Cigna Group by 1,050.0% during the 4th quarter. Activest Wealth Management now owns 138 shares of the health services provider's stock valued at $38,000 after acquiring an additional 126 shares during the period. Finally, True Wealth Design LLC boosted its holdings in shares of Cigna Group by 116.4% during the 4th quarter. True Wealth Design LLC now owns 158 shares of the health services provider's stock valued at $43,000 after acquiring an additional 85 shares during the last quarter. Institutional investors own 86.99% of the company's stock.

Cigna Group Stock Up 2.3%

Shares of CI stock opened at $282.01 on Thursday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $338.89. The stock has a market cap of $74.60 billion, a P/E ratio of 11.95, a P/E/G ratio of 0.96 and a beta of 0.30. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a 50 day simple moving average of $274.22 and a two-hundred day simple moving average of $276.43.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business had revenue of $68.52 billion for the quarter, compared to analysts' expectations of $66.29 billion. During the same quarter last year, the company posted $6.74 EPS. The company's revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts expect that Cigna Group will post 30.4 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a dividend of $1.56 per share. The ex-dividend date is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group's payout ratio is 26.45%.

Insider Activity

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the company's stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares in the company, valued at $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Everett Neville sold 1,719 shares of the firm's stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This trade represents a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.60% of the company's stock.

Analysts Set New Price Targets

A number of analysts have recently commented on the stock. Truist Financial lifted their price target on shares of Cigna Group from $320.00 to $350.00 and gave the stock a "buy" rating in a research note on Tuesday, February 17th. Mizuho set a $330.00 target price on shares of Cigna Group in a report on Friday, May 1st. UBS Group reaffirmed a "buy" rating and issued a $375.00 target price on shares of Cigna Group in a research report on Monday, February 9th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Cigna Group from $301.00 to $304.00 and gave the company a "buy" rating in a research note on Tuesday, February 10th. Finally, TD Cowen increased their price target on Cigna Group from $333.00 to $338.00 and gave the company a "buy" rating in a report on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $338.35.

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.